Page last updated: 2024-08-26

nomegestrol acetate and Mood Disorders

nomegestrol acetate has been researched along with Mood Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Karimi, L; Kulkarni, J; Robertson, E; Thew, C; Thomas, N	1
Derntl, B; Lundin, C; Pletzer, B; Scheuringer, A; Sundström Poromaa, I	1
Baumgart, J; Bengtsdotter, H; Bixo, M; Brynhildsen, J; Gemzell Danielsson, K; Lindh, I; Lundin, C; Malmborg, A; Marions, L; Sundström Poromaa, I	1

Trials

2 trial(s) available for nomegestrol acetate and Mood Disorders

Article	Year
Use of an estradiol-based combined oral contraceptives has no influence on attentional bias or depressive symptoms in healthy women. Psychoneuroendocrinology, 2020, Volume: 113 Topics: Adult; Affect; Affective Symptoms; Anxiety; Anxiety Disorders; Attentional Bias; Contraceptives, Oral, Combined; Depression; Estradiol; Estrogens; Female; Humans; Megestrol; Mood Disorders; Norpregnadienes; Prospective Studies	2020
Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2018, Volume: 23, Issue:1 Topics: Adolescent; Adult; Affect; Alcohol Drinking; Anxiety Disorders; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Estrogens; Feeding and Eating Disorders; Female; Humans; Megestrol; Mental Disorders; Mood Disorders; Norpregnadienes; Progesterone Congeners; Psychiatric Status Rating Scales; Psychological Tests; Risk Factors; Severity of Illness Index; Sweden; Young Adult	2018

Article

Year

Use of an estradiol-based combined oral contraceptives has no influence on attentional bias or depressive symptoms in healthy women.

Psychoneuroendocrinology, 2020, Volume: 113

Topics: Adult; Affect; Affective Symptoms; Anxiety; Anxiety Disorders; Attentional Bias; Contraceptives, Oral, Combined; Depression; Estradiol; Estrogens; Female; Humans; Megestrol; Mood Disorders; Norpregnadienes; Prospective Studies

2020

Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2018, Volume: 23, Issue:1

Topics: Adolescent; Adult; Affect; Alcohol Drinking; Anxiety Disorders; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Estrogens; Feeding and Eating Disorders; Female; Humans; Megestrol; Mental Disorders; Mood Disorders; Norpregnadienes; Progesterone Congeners; Psychiatric Status Rating Scales; Psychological Tests; Risk Factors; Severity of Illness Index; Sweden; Young Adult

2018

Other Studies

1 other study(ies) available for nomegestrol acetate and Mood Disorders

Article	Year
Pilot Data on the Feasibility And Clinical Outcomes of a Nomegestrol Acetate Oral Contraceptive Pill in Women With Premenstrual Dysphoric Disorder. Frontiers in endocrinology, 2021, Volume: 12 Topics: Administration, Oral; Adult; Australia; Contraceptives, Oral, Combined; Feasibility Studies; Female; Follow-Up Studies; Humans; Megestrol; Middle Aged; Mood Disorders; Norpregnadienes; Pilot Projects; Premenstrual Dysphoric Disorder; Prognosis	2021

Article

Year

Pilot Data on the Feasibility And Clinical Outcomes of a Nomegestrol Acetate Oral Contraceptive Pill in Women With Premenstrual Dysphoric Disorder.

Frontiers in endocrinology, 2021, Volume: 12

Topics: Administration, Oral; Adult; Australia; Contraceptives, Oral, Combined; Feasibility Studies; Female; Follow-Up Studies; Humans; Megestrol; Middle Aged; Mood Disorders; Norpregnadienes; Pilot Projects; Premenstrual Dysphoric Disorder; Prognosis

2021